Lombard Odier Transatlantic’s AbbVie ABBV Stock Holding History

Lombard Odier Transatlantic’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$3.79M	Buy	60,140 +660	+1%	+$42.7K	3.63%	5
2016 Q2	$3.68M	Sell	59,480 -100	-0.2%	-$6.09K	3.86%	3
2016 Q1	$3.4M	Sell	59,580 -2,900	-5%	-$162K	3.22%	9
2015 Q4	$3.7M	Buy	62,480 +13,650	+28%	+$786K	3.17%	6
2015 Q3	$2.65M	Buy	48,830 +6,850	+16%	+$446K	2.76%	16
2015 Q2	$2.82M	Sell	41,980 -9,300	-18%	-$607K	2.34%	17
2015 Q1	$3.01M	Buy	+51,280	New	+$3.1M	2.34%	15

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Lombard Odier Transatlantic's ABBV Position: Q3 2016 in Review

Lombard Odier Transatlantic increased its AbbVie (ABBV) stake by 1.1% in Q3 2016, buying an estimated $42.7K and bringing the position to 60,140 shares worth $3.79M. The position accounts for 3.63% of the portfolio, ranked #5.

Lombard Odier Transatlantic first reported a position in ABBV in Q1 2015 and has held it in 7 quarters since. 1,653 funds tracked by Wall St. Rank hold ABBV as of Q3 2016.

Lombard Odier Transatlantic held 60,140 shares of AbbVie worth $3.79M as of Q3 2016.
Lombard Odier Transatlantic bought 660 AbbVie shares in Q3 2016, an estimated $42.7K.
AbbVie made up 3.63% of Lombard Odier Transatlantic's portfolio in Q3 2016, its #5 holding.
Lombard Odier Transatlantic first reported a position in AbbVie in Q1 2015 and has held it in 7 quarters since.
1,653 funds tracked by Wall St. Rank held AbbVie as of Q3 2016.

Based on Lombard Odier Transatlantic's 13F filing for Q3 2016, filed 14 Nov 2016.